STAMBP and hepatocellular carcinoma: Together, by stimulating the expression of MC1R accompanied with its ligand α-MSH treatment, MC1R signaling is further amplified to dampen tumor growth (Fig. 6I), proposing targetable vulnerability for HCC therapy.